All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.
Saved in:
| Title: | All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. |
|---|---|
| Authors: | Li CF; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org., Wei Y; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee HH; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang WC; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan., Xiong Y; Proteomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang R; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The AHMC Dermatology and Research Center, Arcadia, CA, USA., Yao J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu M; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Park J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fu J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang YN; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan., Wang SC; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan.; Department of Biotechnology, Asia University, Taichung, Taiwan., Chou CW; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Division of Hematology/Medical Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan., Ling J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chu YY; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xun Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maitra A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yao W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Yu D; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Chiao PJ; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Ying H; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. HYing@mdanderson.org.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. HYing@mdanderson.org., Hung MC; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhung@cmu.edu.tw.; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw. |
| Source: | Nature communications [Nat Commun] 2026 May 11; Vol. 17 (1). Date of Electronic Publication: 2026 May 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42115161 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+CF%22">Li CF</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Wei+Y%22">Wei Y</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+HH%22">Lee HH</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chang+WC%22">Chang WC</searchLink>; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Xiong+Y%22">Xiong Y</searchLink>; Proteomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yang+R%22">Yang R</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The AHMC Dermatology and Research Center, Arcadia, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yao+J%22">Yao J</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Fu+J%22">Fu J</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+YN%22">Wang YN</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bai+LY%22">Bai LY</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+SC%22">Wang SC</searchLink>; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan.; Department of Biotechnology, Asia University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chou+CW%22">Chou CW</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Division of Hematology/Medical Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ling+J%22">Ling J</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chu+YY%22">Chu YY</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Xun+Z%22">Xun Z</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liang+H%22">Liang H</searchLink>; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Maitra+A%22">Maitra A</searchLink>; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yao+W%22">Yao W</searchLink>; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yu+D%22">Yu D</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chiao+PJ%22">Chiao PJ</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ying+H%22">Ying H</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. HYing@mdanderson.org.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. HYing@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Hung+MC%22">Hung MC</searchLink>; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhung@cmu.edu.tw.; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 May 11; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 May 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42115161 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-72271-5 Languages: – Code: eng Text: English Titles: – TitleFull: All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li CF – PersonEntity: Name: NameFull: Wei Y – PersonEntity: Name: NameFull: Lee HH – PersonEntity: Name: NameFull: Chang WC – PersonEntity: Name: NameFull: Xiong Y – PersonEntity: Name: NameFull: Tang Y – PersonEntity: Name: NameFull: Yang R – PersonEntity: Name: NameFull: Yao J – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Liu M – PersonEntity: Name: NameFull: Park J – PersonEntity: Name: NameFull: Fu J – PersonEntity: Name: NameFull: Wang YN – PersonEntity: Name: NameFull: Bai LY – PersonEntity: Name: NameFull: Wang SC – PersonEntity: Name: NameFull: Chou CW – PersonEntity: Name: NameFull: Ling J – PersonEntity: Name: NameFull: Chu YY – PersonEntity: Name: NameFull: Xun Z – PersonEntity: Name: NameFull: Liang H – PersonEntity: Name: NameFull: Maitra A – PersonEntity: Name: NameFull: Yao W – PersonEntity: Name: NameFull: Yu D – PersonEntity: Name: NameFull: Chiao PJ – PersonEntity: Name: NameFull: Ying H – PersonEntity: Name: NameFull: Hung MC IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 05 Text: 2026 May 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |